Literature DB >> 20117433

The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study.

Aaron M From1, Christopher G Scott, Horng H Chen.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the outcomes of pre-clinical diastolic dysfunction in diabetic patients.
BACKGROUND: Studies have reported a high prevalence of pre-clinical diastolic dysfunction among patients with diabetes mellitus.
METHODS: We identified all diabetic patients with a tissue Doppler imaging assessment of diastolic function in Olmsted County, Minnesota, from 2001 to 2007. Diastolic dysfunction was defined as a passive transmitral left ventricular (LV) inflow velocity to tissue Doppler imaging velocity of the medial mitral annulus during passive filling (E/e') ratio >15. The main outcome was the development of heart failure (HF). Secondary outcomes were the development of atrial fibrillation and death.
RESULTS: Overall, 1,760 diabetic patients with a tissue Doppler echocardiographic assessment of diastolic function were identified; 411 (23%) patients had diastolic dysfunction. Using multivariable Cox's proportional hazard modeling, we determined that for every 1-U increase in the passive transmitral LV inflow velocity to tissue Doppler imaging velocity of the medial mitral annulus during passive filling (E/e') ratio, the hazard ratio (HR) of HF increased by 3% (HR: 1.03; 95% confidence interval [CI]: 1.01 to 1.06; p = 0.006) and that diastolic dysfunction was associated with the subsequent development of HF after adjustment for age, sex, body mass index, hypertension, coronary disease, and echocardiographic parameters (HR: 1.61; 95% CI: 1.17 to 2.20; p = 0.003). The cumulative probability of the development of HF at 5 years for diabetic patients with diastolic dysfunction was 36.9% compared with 16.8% for patients without diastolic dysfunction (p < 0.001). Furthermore, diabetic patients with diastolic dysfunction had a significantly higher mortality rate compared with those without diastolic dysfunction.
CONCLUSIONS: We demonstrated that an increase in the passive transmitral LV inflow velocity to tissue Doppler imaging velocity of the medial mitral annulus during passive filling (E/e') ratio in diabetic patients is associated with the subsequent development of HF and increased mortality independent of hypertension, coronary disease, or other echocardiographic parameters. Copyright (c) 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20117433      PMCID: PMC3878075          DOI: 10.1016/j.jacc.2009.12.003

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

1.  Evidence for cardiomyopathy in familial diabetes mellitus.

Authors:  T J Regan; M M Lyons; S S Ahmed; G E Levinson; H A Oldewurtel; M R Ahmad; B Haider
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

Review 2.  Epidemiology of the diabetic heart.

Authors:  Dimitrios N Tziakas; Georgios K Chalikias; Juan Carlos Kaski
Journal:  Coron Artery Dis       Date:  2005-11       Impact factor: 1.439

3.  Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study).

Authors:  M Galderisi; K M Anderson; P W Wilson; D Levy
Journal:  Am J Cardiol       Date:  1991-07-01       Impact factor: 2.778

4.  History of the Rochester Epidemiology Project.

Authors:  L J Melton
Journal:  Mayo Clin Proc       Date:  1996-03       Impact factor: 7.616

5.  A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.

Authors:  M A Quinones; A D Waggoner; L A Reduto; J G Nelson; J B Young; W L Winters; L G Ribeiro; R R Miller
Journal:  Circulation       Date:  1981-10       Impact factor: 29.690

6.  Relationship of impaired glucose tolerance to left ventricular structure and function: The Strong Heart Study.

Authors:  A Ilercil; R B Devereux; M J Roman; M Paranicas; M J O'grady; T K Welty; D C Robbins; R R Fabsitz; B V Howard; E T Lee
Journal:  Am Heart J       Date:  2001-06       Impact factor: 4.749

7.  Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study.

Authors:  M Lee; J M Gardin; J C Lynch; V E Smith; R P Tracy; P J Savage; M Szklo; B J Ward
Journal:  Am Heart J       Date:  1997-01       Impact factor: 4.749

8.  Cardiomyopathy in childhood diabetes mellitus: incidence, time of onset, and relation to metabolic control.

Authors:  G Hausdorf; U Rieger; P Koepp
Journal:  Int J Cardiol       Date:  1988-05       Impact factor: 4.164

9.  Trends in heart failure incidence and survival in a community-based population.

Authors:  Véronique L Roger; Susan A Weston; Margaret M Redfield; Jens P Hellermann-Homan; Jill Killian; Barbara P Yawn; Steven J Jacobsen
Journal:  JAMA       Date:  2004-07-21       Impact factor: 56.272

Review 10.  Diabetic cardiomyopathy.

Authors:  K S Spector
Journal:  Clin Cardiol       Date:  1998-12       Impact factor: 2.882

View more
  139 in total

1.  Detection of early diastolic alterations by tissue Doppler imaging in untreated childhood-onset essential hypertension.

Authors:  Ngozi C Agu; Karen McNiece Redwine; Cynthia Bell; Kathleen Marie Garcia; David S Martin; Tim S Poffenbarger; John T Bricker; Ronald J Portman; Monesha Gupta-Malhotra
Journal:  J Am Soc Hypertens       Date:  2014-02-24

Review 2.  Cardiac Abnormalities in Youth with Obesity and Type 2 Diabetes.

Authors:  Fida Bacha; Samuel S Gidding
Journal:  Curr Diab Rep       Date:  2016-07       Impact factor: 4.810

3.  Sustained cardiac remodeling after a short-term very low calorie diet in type 2 diabetes mellitus patients.

Authors:  Jacqueline T Jonker; Marieke Snel; Sebastiaan Hammer; Ingrid M Jazet; Rutger W van der Meer; Hanno Pijl; A Edo Meinders; Albert de Roos; Johannes W A Smit; Johannes A Romijn; Hildo J Lamb
Journal:  Int J Cardiovasc Imaging       Date:  2013-10-16       Impact factor: 2.357

Review 4.  Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies.

Authors:  Maythem Saeed; Steven W Hetts; Robert Jablonowski; Mark W Wilson
Journal:  World J Cardiol       Date:  2014-11-26

5.  Insulin supplementation attenuates cancer-induced cardiomyopathy and slows tumor disease progression.

Authors:  James T Thackeray; Stefan Pietzsch; Britta Stapel; Melanie Ricke-Hoch; Chun-Wei Lee; Jens P Bankstahl; Michaela Scherr; Jörg Heineke; Gesine Scharf; Arash Haghikia; Frank M Bengel; Denise Hilfiker-Kleiner
Journal:  JCI Insight       Date:  2017-05-18

6.  Left ventricular mechanical dyssynchrony assessment in long-standing type II diabetes mellitus patients with normal gated SPECT-MPI.

Authors:  Dharmender Malik; Bhagwant Mittal; Ashwani Sood; Madan Parmar; Gurvinder Kaur; Ajay Bahl
Journal:  J Nucl Cardiol       Date:  2018-02-01       Impact factor: 5.952

Review 7.  Is diabetic cardiomyopathy a specific entity?

Authors:  Mitja Letonja; Danijel Petrovič
Journal:  World J Cardiol       Date:  2014-01-26

8.  Empagliflozin and left ventricular diastolic function following an acute coronary syndrome in patients with type 2 diabetes.

Authors:  Nick S R Lan; Bu B Yeap; P Gerry Fegan; Gillian Green; James M Rankin; Girish Dwivedi
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-21       Impact factor: 2.357

9.  Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study.

Authors:  Wilfried Dinh; Mark Lankisch; Werner Nickl; Daniel Scheyer; Thomas Scheffold; Frank Kramer; Thomas Krahn; Rolf M Klein; Michael Coll Barroso; Reiner Füth
Journal:  Cardiovasc Diabetol       Date:  2010-10-15       Impact factor: 9.951

10.  The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota.

Authors:  Sanjay Dandamudi; Joshua Slusser; Douglas W Mahoney; Margaret M Redfield; Richard J Rodeheffer; Horng H Chen
Journal:  J Card Fail       Date:  2014-02-24       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.